The rational use of systemic isotretinoin: A call for moderation | Zendy

Werner Sinclair | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The rational use of systemic isotretinoin: A call for moderation

Author(s) -

Werner Sinclair

Publication year - 2012

Publication title -

south african medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.527

H-Index - 57

eISSN - 2078-5135

pISSN - 0256-9574

DOI - 10.7196/samj.5310

Subject(s) - medicine , isotretinoin , acne , limiting , warrant , safer , moderation , malpractice , intensive care medicine , risk analysis (engineering) , dermatology , computer security , law , mechanical engineering , social psychology , psychology , computer science , financial economics , political science , engineering , economics

Systemic isotretinoin effectively treats all forms of acne vulgaris. However, it has many side-effects, some potentially serious, that warrant limiting its use to serious cases of acne. Inappropriate use in large numbers of patients puts prescribers at risk of malpractice litigation should serious side-effects occur where safer alternative treatments were available. Doctors also risk losing access to the drug should authorities limit its use to reduce the occurrence of side-effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research